La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.

Identifieur interne : 001610 ( Main/Exploration ); précédent : 001609; suivant : 001611

Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.

Auteurs : V. Marchand-Pauvert [France] ; A. Gerdelat-Mas ; F. Ory-Magne ; F. Calvas ; D. Mazevet ; S. Meunier ; C. Brefel-Courbon ; M. Vidailhet ; M. Simonetta-Moreau

Source :

RBID : pubmed:20943434

English descriptors

Abstract

To investigate the contribution of group II spinal pathways in Parkinsonian upper limb rigidity and the modulation of spinal excitability of group I and group II pathways by L-DOPA and subthalamic nucleus-high-frequency stimulation (STN-HFS).

DOI: 10.1016/j.clinph.2010.08.015
PubMed: 20943434


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.</title>
<author>
<name sortKey="Marchand Pauvert, V" sort="Marchand Pauvert, V" uniqKey="Marchand Pauvert V" first="V" last="Marchand-Pauvert">V. Marchand-Pauvert</name>
<affiliation wicri:level="3">
<nlm:affiliation>UPMC Université de Paris 06, ER 6, F-75005 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Université de Paris 06, ER 6, F-75005 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gerdelat Mas, A" sort="Gerdelat Mas, A" uniqKey="Gerdelat Mas A" first="A" last="Gerdelat-Mas">A. Gerdelat-Mas</name>
</author>
<author>
<name sortKey="Ory Magne, F" sort="Ory Magne, F" uniqKey="Ory Magne F" first="F" last="Ory-Magne">F. Ory-Magne</name>
</author>
<author>
<name sortKey="Calvas, F" sort="Calvas, F" uniqKey="Calvas F" first="F" last="Calvas">F. Calvas</name>
</author>
<author>
<name sortKey="Mazevet, D" sort="Mazevet, D" uniqKey="Mazevet D" first="D" last="Mazevet">D. Mazevet</name>
</author>
<author>
<name sortKey="Meunier, S" sort="Meunier, S" uniqKey="Meunier S" first="S" last="Meunier">S. Meunier</name>
</author>
<author>
<name sortKey="Brefel Courbon, C" sort="Brefel Courbon, C" uniqKey="Brefel Courbon C" first="C" last="Brefel-Courbon">C. Brefel-Courbon</name>
</author>
<author>
<name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name>
</author>
<author>
<name sortKey="Simonetta Moreau, M" sort="Simonetta Moreau, M" uniqKey="Simonetta Moreau M" first="M" last="Simonetta-Moreau">M. Simonetta-Moreau</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20943434</idno>
<idno type="pmid">20943434</idno>
<idno type="doi">10.1016/j.clinph.2010.08.015</idno>
<idno type="wicri:Area/PubMed/Corpus">000977</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000977</idno>
<idno type="wicri:Area/PubMed/Curation">000937</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000937</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000937</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000937</idno>
<idno type="wicri:Area/Ncbi/Merge">000C31</idno>
<idno type="wicri:Area/Ncbi/Curation">000C31</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C31</idno>
<idno type="wicri:Area/Main/Merge">001691</idno>
<idno type="wicri:Area/Main/Curation">001610</idno>
<idno type="wicri:Area/Main/Exploration">001610</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.</title>
<author>
<name sortKey="Marchand Pauvert, V" sort="Marchand Pauvert, V" uniqKey="Marchand Pauvert V" first="V" last="Marchand-Pauvert">V. Marchand-Pauvert</name>
<affiliation wicri:level="3">
<nlm:affiliation>UPMC Université de Paris 06, ER 6, F-75005 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Université de Paris 06, ER 6, F-75005 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gerdelat Mas, A" sort="Gerdelat Mas, A" uniqKey="Gerdelat Mas A" first="A" last="Gerdelat-Mas">A. Gerdelat-Mas</name>
</author>
<author>
<name sortKey="Ory Magne, F" sort="Ory Magne, F" uniqKey="Ory Magne F" first="F" last="Ory-Magne">F. Ory-Magne</name>
</author>
<author>
<name sortKey="Calvas, F" sort="Calvas, F" uniqKey="Calvas F" first="F" last="Calvas">F. Calvas</name>
</author>
<author>
<name sortKey="Mazevet, D" sort="Mazevet, D" uniqKey="Mazevet D" first="D" last="Mazevet">D. Mazevet</name>
</author>
<author>
<name sortKey="Meunier, S" sort="Meunier, S" uniqKey="Meunier S" first="S" last="Meunier">S. Meunier</name>
</author>
<author>
<name sortKey="Brefel Courbon, C" sort="Brefel Courbon, C" uniqKey="Brefel Courbon C" first="C" last="Brefel-Courbon">C. Brefel-Courbon</name>
</author>
<author>
<name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name>
</author>
<author>
<name sortKey="Simonetta Moreau, M" sort="Simonetta Moreau, M" uniqKey="Simonetta Moreau M" first="M" last="Simonetta-Moreau">M. Simonetta-Moreau</name>
</author>
</analytic>
<series>
<title level="j">Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</title>
<idno type="eISSN">1872-8952</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Deep Brain Stimulation</term>
<term>Electromyography</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (pharmacology)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Muscle Rigidity (therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Reflex (drug effects)</term>
<term>Reflex (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Reflex</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Reflex</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Muscle Rigidity</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Deep Brain Stimulation</term>
<term>Electromyography</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To investigate the contribution of group II spinal pathways in Parkinsonian upper limb rigidity and the modulation of spinal excitability of group I and group II pathways by L-DOPA and subthalamic nucleus-high-frequency stimulation (STN-HFS).</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Brefel Courbon, C" sort="Brefel Courbon, C" uniqKey="Brefel Courbon C" first="C" last="Brefel-Courbon">C. Brefel-Courbon</name>
<name sortKey="Calvas, F" sort="Calvas, F" uniqKey="Calvas F" first="F" last="Calvas">F. Calvas</name>
<name sortKey="Gerdelat Mas, A" sort="Gerdelat Mas, A" uniqKey="Gerdelat Mas A" first="A" last="Gerdelat-Mas">A. Gerdelat-Mas</name>
<name sortKey="Mazevet, D" sort="Mazevet, D" uniqKey="Mazevet D" first="D" last="Mazevet">D. Mazevet</name>
<name sortKey="Meunier, S" sort="Meunier, S" uniqKey="Meunier S" first="S" last="Meunier">S. Meunier</name>
<name sortKey="Ory Magne, F" sort="Ory Magne, F" uniqKey="Ory Magne F" first="F" last="Ory-Magne">F. Ory-Magne</name>
<name sortKey="Simonetta Moreau, M" sort="Simonetta Moreau, M" uniqKey="Simonetta Moreau M" first="M" last="Simonetta-Moreau">M. Simonetta-Moreau</name>
<name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name>
</noCountry>
<country name="France">
<region name="Île-de-France">
<name sortKey="Marchand Pauvert, V" sort="Marchand Pauvert, V" uniqKey="Marchand Pauvert V" first="V" last="Marchand-Pauvert">V. Marchand-Pauvert</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001610 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001610 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:20943434
   |texte=   Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20943434" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024